Deerfield Management’s Mirum Pharmaceuticals MIRM Stock Holding History

Deerfield Management’s Portfolio MIRM Stock Details MIRM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-2,032,335	Closed	-$48.8M	–	107
2023 Q1	$48.8M	Hold	2,032,335	–	–	1.09%	27
2022 Q4	$39.6M	Hold	2,032,335	–	–	0.82%	35
2022 Q3	$42.7M	Sell	2,032,335 -1,212,099	-37%	-$29.2M	0.85%	39
2022 Q2	$63.1M	Sell	3,244,434 -38,478	-1%	-$908K	1.3%	24
2022 Q1	$72.3M	Hold	3,282,912	–	–	1.62%	22
2021 Q4	$52.4M	Hold	3,282,912	–	–	1.1%	30
2021 Q3	$65.4M	Sell	3,282,912 -166,000	-5%	-$2.7M	1.28%	21
2021 Q2	$59.6M	Hold	3,448,912	–	–	1.06%	22
2021 Q1	$68.4M	Hold	3,448,912	–	–	1.44%	18
2020 Q4	$60.2M	Hold	3,448,912	–	–	1.19%	21
2020 Q3	$66.5M	Hold	3,448,912	–	–	1.62%	18
2020 Q2	$67.1M	Hold	3,448,912	–	–	1.95%	13
2020 Q1	$48.3M	Hold	3,448,912	–	–	1.53%	19
2019 Q4	$84.6M	Hold	3,448,912	–	–	2.7%	9
2019 Q3	$34.7M	Buy	+3,448,912	New	+$42.3M	1.41%	17

Other funds holding MIRM

FLSM

Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return

EAM

Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return

NMC

NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

RSCM

Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return

NHAS

Novo Holdings A/S Hellerup, Denmark $1.23B AUM 81.32% 1-Year Est. Return

RVM

RiverVest Venture Management St. Louis, Missouri $6.84M AUM 7.71% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Deerfield Management's MIRM Position: Q2 2023 in Review

Deerfield Management sold out of Mirum Pharmaceuticals (MIRM) in Q2 2023, closing a stake of 2,032,335 shares — an estimated $48.8M sold.

Deerfield Management first reported a position in MIRM in Q3 2019 and held it in 15 quarters. The position peaked at $84.6M in Q4 2019. 146 funds tracked by Wall St. Rank hold MIRM as of Q2 2023.

Deerfield Management reported no remaining Mirum Pharmaceuticals position as of Q2 2023 after selling out during the quarter.
Deerfield Management sold 2,032,335 Mirum Pharmaceuticals shares in Q2 2023, an estimated $48.8M.
Deerfield Management first reported a position in Mirum Pharmaceuticals in Q3 2019 and held it in 15 quarters.
Deerfield Management's Mirum Pharmaceuticals position peaked at $84.6M in Q4 2019.
146 funds tracked by Wall St. Rank held Mirum Pharmaceuticals as of Q2 2023.

Based on Deerfield Management's 13F filing for Q2 2023, filed 14 Aug 2023.